AKT1 and myocardial infarction: Researchers demonstrated that resistin can distinctly reduce apoptotic rate and post-ischemic myocardial infarction area via PI3K/Akt/PKC or ERK1/2-matrix metalloproteinase 9 dependent pathways and thus against I/R injury [135, 136].